Alzheimer’s & Memory Loss During Sleep | Brain Health

by Grace Chen

LONDON, February 1, 2026 — A surprising breakdown in the brain’s “replay” function during rest may be a key factor in the development of Alzheimer’s disease, new research suggests. The study, conducted in mice, reveals that this disruption hinders the brain’s ability to solidify recent experiences into lasting memories.

How Brains Cement Memories—and What Goes Wrong in Alzheimer’s

Scientists have pinpointed a glitch in the brain’s memory-consolidation process that could lead to new diagnostic tools and treatments.

  • Alzheimer’s disease isn’t just about plaque buildup; it’s about how those plaques interfere with fundamental brain processes.
  • The brain normally replays experiences during rest to strengthen memories, but this process is disrupted in Alzheimer’s.
  • This disruption manifests as disorganized brain activity and unstable memory signals.
  • Restoring this replay function could be a target for future Alzheimer’s treatments.

Alzheimer’s disease, characterized by memory loss and navigational difficulties, is driven by the accumulation of harmful proteins and plaques in the brain. But exactly how these changes disrupt normal brain function has remained a mystery. Researchers are now focusing on the brain’s ability to replay recent experiences during rest – a process vital for memory formation.

The Brain’s Internal Rewind Button

This replay activity occurs primarily in the hippocampus, a brain region crucial for learning and memory. During periods of quiet, specific neurons called place cells activate in sequences that mirror recent journeys or experiences. These place cells, discovered by Nobel laureate Professor John O’Keefe, fire in a specific order as we navigate our surroundings. Later, during rest, the brain reactivates these same cells in the same sequence, essentially re-experiencing the event and solidifying it as a memory.

To investigate this process, researchers tracked brain activity in mice as they explored a maze, then rested. Using specialized electrodes, they monitored roughly 100 individual place cells simultaneously. This allowed them to compare replay patterns in healthy mice with those exhibiting amyloid pathology – the hallmark plaques of Alzheimer’s disease.

Scrambled Signals, Fading Memories

In mice with amyloid plaques, replay events occurred with the same frequency as in healthy mice, but the patterns were profoundly disorganized. Instead of reinforcing memories, the coordinated activity of place cells became scrambled. The researchers also found that place cells in affected mice became less stable over time, failing to reliably represent specific locations, particularly after rest periods when replay should have strengthened those signals.

What happens when memory replay fails? The brain continues to *try* to consolidate memories, but the process itself is fundamentally broken, leading to a failure in memory consolidation visible at the level of individual neurons.

This disruption had a clear impact on behavior. Mice with disorganized replay performed poorly in the maze, repeatedly revisiting already-explored paths and demonstrating an inability to remember where they had been.

“We’ve uncovered a breakdown in how the brain consolidates memories, visible at the level of individual neurons,” said co-lead author Professor Caswell Barry. “What’s striking is that replay events still occur – but they’ve lost their normal structure. It’s not that the brain stops trying to consolidate memories; the process itself has gone wrong.”

Hope for Earlier Detection and Targeted Treatments

These findings offer potential avenues for both earlier detection and more effective treatments for Alzheimer’s. Researchers are exploring ways to restore normal replay activity, potentially through manipulation of the neurotransmitter acetylcholine, which is already targeted by existing Alzheimer’s medications.

“We hope our findings could help develop tests to detect Alzheimer’s early, before extensive damage has occurred, or lead to new treatments targeting this replay process,” Professor Barry added. “By understanding the mechanism better, we hope to make such treatments more effective.”

The research was conducted by scientists in the Faculties of Life Sciences and Brain Sciences, with support from the Cambridge Trust, Wellcome, and the Masonic Charitable Foundation.

You may also like

Leave a Comment